Gosreports：ElectroceuticalsBioelectric Medicine Market Forecast to 2021

2. Electroceuticals/Bioelectric Medicine Market by Product (Pacemakers, Cochlear Implants, Spinal Cord Stimulators), Type of Device (Implantable, Non-Invasive), Application (Arrhythmia, Depression, Migraine), End User (Hospitals) – Global Forecast to 2021 • http://www.gosreports.com

3. Electroceuticals/Bioelectric Medicine Market by Product (Pacemakers, Cochlear Implants, Spinal Cord Stimulators), Type of Device (Implantable, Non-Invasive), Application (Arrhythmia, Depression, Migraine), End User (Hospitals) – Global Forecast to 2021 • “The global electroceuticals/bioelectric medicine market is expected to reach USD 25.20 billion by 2021 from USD 17.20 billion in 2016, growing at a CAGR of 7.9% from 2016 to 2021. • http://www.gosreports.com • Electroceuticals are medical devices that use electrical impulses to modulate the body’s neural circuits as an alternative to drug-based interventions. These electroceutical devices read and modify electrical signals passing along the nerves of the body, including irregular or altered impulses that can occur in association with a broad range of diseases.

4. The implantable cardioverter defibrillators segment is expected to account for the largest share of the electroceuticals/bioelectric medicine market, by product, in 2016. Increasing sudden cardiac arrest (SCA) leading to cardiovascular death, technological advancements in ICDs, and increasing arrhythmia is contributing to the large share of this segment. The implantable electroceutical devices segment is expected to account for the largest share of the electroceuticals/bioelectric medicine market, by type of device, in 2016. • http://www.gosreports.com • The rising research in this industry and collaborations and partnerships to development electroceutical devices, these devices providing continuous treatment within the body, and providing an environment for the easy treatment of patients is driving growth in this market segment. The hospitals segment is estimated to account for the largest share of the electroceuticals/bioelectric medicine market, by end user, in 2016. This can be attributed to increasing burden of diseases such as cardiac arrhythmias, Parkinson’s, Alzheimer’s, retinitis pigmentosa, epilepsy, and depression; and increasing awareness about electroceuticals.

5. North America is expected to account for the largest share of the global electroceuticals/bioelectric medicine market in 2016, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). The large share of the North American region can be attributed to the rising prevalence of arrhythmia, growing prevalence of chronic diseases, expected approvals for retinal implants, increasing regulatory approvals in the U.S., increasing burden of cancer and diabetes, and increase in hearing loss owing to rising aging population in Canada, among others. • http://www.gosreports.com • The Asia-Pacific region is expected to witness the highest growth rate in the forecast period, mainly due to the rising adoption of neurostimulation, increasing cases of diabetes, increasing prevalence of hearing loss, increasing geriatric population, conferences on electroceutical devices, increasing prevalence of Parkinson’s Disease, and regulatory approvals of cochlear implants in the Asia-Pacific region.

6. “TABLE OF CONTENTS • 1 INTRODUCTION 20 • 1.1 OBJECTIVES OF STUDY 20 • 1.2 MARKET DEFINITION 20 • 1.3 MARKET SCOPE 20 • 1.3.1 MARKETS COVERED 21 • 1.3.2 YEARS CONSIDERED FOR THE STUDY 21 • 1.4 CURRENCY 22 • 1.5 LIMITATIONS 22 • 1.6 STAKEHOLDERS 22 • 2 RESEARCH METHODOLOGY 23 • 2.1 RESEARCH METHODOLOGY STEPS 23 • 2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 24

7. 8 GLOBAL ELECTROCEUTICALS MARKET, BY APPLICATION 80 • 8.1 INTRODUCTION 81 • 8.2 CARDIAC PACEMAKERS AND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY APPLICATION 82 • 8.2.1 ARRHYTHMIA 82 • 8.3 SPINAL CORD STIMULATORS (SCS) MARKET, BY APPLICATION 83 • 8.3.1 CHRONIC PAIN 83 • 8.3.2 FAILED BACK SYNDROME (FBSS) 85 • 8.3.3 ISCHEMIA 86

8. Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies. • 13 APPENDIX 201 • 13.1 DISCUSSION GUIDE 201 • 13.2 COMPANY DEVELOPMENTS (2013-2016) 206 • 13.2.1 MEDTRONIC PLC 206 • 13.2.2 ST. JUDE MEDICAL, INC. 207 • 13.2.3 BOSTON SCIENTIFIC CORPORATION 209 • 13.2.4 COCHLEAR LIMITED 211 • 13.2.5 LIVANOVA PLC 211 • 13.2.6 BIOTRONIK 212 • 13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 214 • 13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 216 • 13.5 AVAILABLE CUSTOMIZATIONS 217 • 13.7 RELATED REPORTS 218

9. About Gosreports： • Gosreports International Inc. is one of the leading distributors of market research reports in the world today. We host more than 40,000 research products from the world’s top publication houses. Our web-based platform offers an unmatched collection of market research reports, company reviews, databooks, articles, periodical publications, databases, and much more, delivered by the successful and well-established publishers with whom we are currently in partnership. • Contacts Us • Joanna | Executive - International Business and partner Relations • E-mail:info@gosreports.com | Tel: 001-510-400-8520 • Web: www.gosreports.com • 385 S LEMON AVE #E276, WALNUT CA 91789, USA • Joanna Account Manager • 001-510-400-8520 • email • www.gosreports.com